市场调查报告书
商品编码
1541685
胶囊内视镜市场报告(依产品(小肠、食道、结肠)、配件(无线胶囊、工作站和记录器)、应用(OGIB、克隆氏症、小肠肿瘤)和地区 2024-2032Capsule Endoscopy Market Report by Product (Small Bowel, Esophageal, Colon), Accessory (Wireless Capsule, Workstation and Recorder), Application (OGIB, Crohn's, Small Intestine Tumors), and Region 2024-2032 |
2023年全球胶囊内视IMARC Group市场规模达4.859亿美元。
胶囊内视镜检查是指用于取得食道、胃和小肠影像的诊断程序。它涉及使用小型胶囊封装的相机,该相机被吞下并通过胃肠道(GI)。此手术是微创(MI)、无痛且不需要麻醉。它使医生能够拍摄数千张内臟器官的图像,这是透过传统使用的成像解决方案无法获得的。因此,胶囊内视镜广泛应用于胃肠道癌症、慢性腹痛、克隆氏症、乳糜泻、出血过多和溃疡等疾病的诊断和治疗。
全球胃肠道疾病和大肠癌盛行率的增加是推动市场成长的关键因素之一。此外,大众对治疗此类疾病的无痛和心肌梗塞可视化手术的认识不断提高,这也推动了市场的成长。食道、小肠和结肠胶囊内视镜广泛应用于医院和其他医疗中心,用于及时诊断和改善患者护理。与此一致的是,老年人口的增加也促进了市场的成长,老年人口更容易患发炎性肠道疾病、不明性胃肠道出血(OGIB)和阑尾炎等疾病。此外,各种技术进步,例如具有更长电池寿命和 Wi-fi 相容性的胶囊的开发,也是其他促进成长的因素。产品製造商也在开发用户友好的、具有 360 度全景的高解析度相机。其他因素,包括消费者支出能力的提高以及医疗保健基础设施的广泛改善,预计将推动市场成长。
The global capsule endoscopy market size reached US$ 485.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 938.4 Million by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032.
Capsule endoscopy refers to a diagnostic procedure used for obtaining images of the esophagus, stomach and small intestines. It involves the use of a small capsule-encased camera, which is swallowed and passed through the gastrointestinal (GI) tract. The procedure is minimally invasive (MI), painless and does not require the administration of anesthesia. It enables the physician to take thousands of images of the internal organs which are not accessible through the traditionally used imaging solutions. As a result, capsule endoscopy is widely used in the diagnosis and treatment of gastrointestinal cancer, chronic abdominal pain, Crohn's disease, celiac disease, excessive bleeding and ulcers.
The increasing prevalence of gastrointestinal disorders and colorectal cancer across the globe is one of the key factors driving the growth of the market. Moreover, rising awareness among the masses regarding the availability of painless and MI visualization procedures for the treatment of such ailments is providing a thrust to the market growth. Esophageal, small bowel and colon capsule endoscopes are extensively used across hospitals and other healthcare centers for timely diagnosis and improved patient care. In line with this, the rising geriatric population, which is more susceptible to ailments, such as inflammatory bowel disease, Obscure Gastrointestinal Bleeding (OGIB) and appendicitis, is also contributing to the growth of the market. Additionally, various technological advancements, such as the development of capsules with longer battery life and Wi-fi compatibility, are acting as other growth-inducing factors. Product manufacturers are also developing user-friendly and high-resolution cameras with a 360-degree panoramic view. Other factors, including rising expenditure capacities of the consumers, along with extensive improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global capsule endoscopy market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, accessory and application.
Small Bowel
Esophageal
Colon
Wireless Capsule
Workstation and Recorder
OGIB
Crohn's
Small Intestine Tumors
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, CapsoVision Inc., Check Cap Ltd, Fujifilm Holdings Corporation, IntroMedic Co. Ltd, Jinshan Science & Technology (Group) Co. Ltd., Medtronic plc, Olympus Corporation, RF Co. Ltd. and Shangxian Minimal Invasive Inc.